OXELTIS
Pharmaceutical Manufacturing • 
Grabels, Occitanie, France • 21-50 Employees
Company overview
| Headquarters | 1682 rue de la Valsière, BP 7247, Montpellier Cedex 4, 34086, FR |
| Phone number | +33499235036 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Oncology, Antibiotics, Phosphoramidites, Custom Synthesis, Heterocyclic, Medicinal Chemistry, Contract Research, Antivirals, Iminosugars, Macrocyclic, Monosaccharides And Oligosaccharides, Nucleos(T)Ides, Phosphorus Chemistry, Sugar Phosphates, Unnatural Sugars, Protacs, Macrocycles, Cyclic), Peptides (Linear, Pseudopeptides, Stapled |
| Founded | 2010 |
| Employees | 21-50 |
| Socials |
Key Contacts at OXELTIS
Jean-Marc Allaire
Co-Founder & Ceo
Stéphane Salamone
Chemistry Director
OXELTIS Email Formats
OXELTIS uses 2 email formats. The most common is {last name}.{first initial} (e.g., doe.j@oxeltis.com), used 85.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name}.{first initial} | doe.j@oxeltis.com | 85.7% |
{first name}.{last name} | john.doe@oxeltis.com | 14.3% |
About OXELTIS
OXELTIS is an independent medchem oriented service company managed by former researchers from Idenix Pharmaceuticals and located in Montpellier - France. Oxeltis is a company that delivers integrated solutions for managing and executing medicinal and fine organic chemistry projects. We run FTE programs (hit to lead optimization) with an expertise in some specialty chemistry such as macrocycles (pseudopeptides), mono & poly/oligosaccharides (sugar phosphates, iminosugars, saccharidic antigens…) nucleos(t)ides (modified nucleosides, phosphoramidites…), short peptides, linkers and PROTACs (Ligands E3 CRBN ligase library ) applied to discovery programs in oncology, antivirals and antibiotics mainly. OXELTIS client portfolio includes 40+ European and US companies from biotech to top 10 pharmaceutical companies. With its team of experienced medchem chemists, OXELTIS is proactive in providing rapid, high quality and competitive work. Specific expertise: - Contract research in medicinal chemistry, FTE programs for hit to lead optimization in different fields including antivirals, anticancer and antibiotics. - Fee-for-service custom synthesis expertise in heterocycles (in various fields), modified sugars (sugar phosphates, iminosugars, unnatural sugars…monosaccharides and oligosaccharides...), nucleoside/nucleotide (sugar and base-modified nucleosides, phosphoramidites…), macrocycles (e.g. antiviral antiproteases) . https://oxeltis.com/ https://twitter.com/Oxeltis_CRO
OXELTIS revenue & valuation
| Annual revenue | $2,053,320 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $6,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
OXELTIS has 13 employees across 3 departments.
Departments
Number of employees
Funding Data
OXELTIS has never raised funding before.
OXELTIS Tech Stack
Discover the technologies and tools that power OXELTIS's digital infrastructure, from frameworks to analytics platforms.
Web servers
Font scripts
Security
JavaScript libraries
JavaScript libraries
Form builders
Programming languages
Font scripts
Authentication
Blogs
JavaScript libraries
Databases
Spain
United States
Canada
United Kingdom
Frequently asked questions
4.8
40,000 users
